Notably, our findings are consistent with a recent report from a genome-wide analysis of genes critical for sorafenib resistance.43 The study found that phosphoglycerate dehydrogenase (PHGDH) is a critical driver for HCC sorafenib resistance. The gene discussed is PHGDH; the disease is hepatocellular carcinoma.